1. Towards a translational health information language

   • Amnon Shabo

   Meeting abstract Open access 11 February 2014 Article: A51

   

2. Big data versus small data analysis towards personalized medicine practice

   • Mira Marcus-Kalish

   Meeting abstract Open access 11 February 2014 Article: A52

3. Systems patientomics: the virtual in-silico patient

   • Dimiter V Dimitrov

   Meeting abstract Open access 11 February 2014 Article: A53

4. Genetic pass as a background of predictive, preventive, personalized medicine options and limitations

   • Vladislav S Baranov

   Meeting abstract Open access 11 February 2014 Article: A54

5. The expression of signal molecules in buccal epithelium: new abilities of molecular personalized diagnosis of human diseases

   • Michail A Paltsev
   • Igor M Kvetnoy
   • Igor B Oleksyuk

   Meeting abstract Open access 11 February 2014 Article: A55

6. The BRI-on-chip disposable test device opens up substantial savings potentials in urolithiasis treatment

   • Norbert Laube
   • Wolfgang Berg
   • Heinz Busch

   Meeting abstract Open access 11 February 2014 Article: A56

   

7. Evaluation of hTERC (3q26) gain by fluorescence in situ hybridization (FISH) to predict the behavior of oral epithelial precursor lesions

   • Silvia Gabba
   • Elisa Giannini
   • Vittorio Grazioli

   Meeting abstract Open access 11 February 2014 Article: A57

   

8. Evaluation of biomarkers for diagnosnostic decision making in patients with gout using novel mathematical model. Complex PPPM approach

   • Rostyslav V Bubnov
   • Ivan M Melnyk

   Meeting abstract Open access 11 February 2014 Article: A58

9. Information and communication technology in personalized medicine: a clinical use-case for hepatocellular cancer

   • Leonard Berliner
   • Heinz U Lemke
   • Irene Bargellini

   Meeting abstract Open access 11 February 2014 Article: A59

10. Multimodal approaches in female healthcare: the role of integrative bioinformatics

    • Olga Golubnitschaja

    Meeting abstract Open access 11 February 2014 Article: A60

    

11. Streamlining genetic testing by standardizing its report formats and exchange among all stakeholders

    • Amnon Shabo

    Meeting abstract Open access 11 February 2014 Article: A61

    

12. Hematopoietic stem cell transplantation (HSCT) as an example of personalized approach in the management of individual disease

    • Hele Everaus

    Meeting abstract Open access 11 February 2014 Article: A62

13. The Bonn-Risk-Index for determination of the risk of urolith formation and other metabolic diseases

    • Norbert Laube
    • Wolfgang Berg
    • Heinz Busch

    Meeting abstract Open access 11 February 2014 Article: A63

14. IT- technology for vascular monitoring as an evidential base in prevention and prediction of a vascular pathology

    • Ulyana B Lushchyk
    • Viktor V Novytskyy
    • Andriy O Kovpak

    Meeting abstract Open access 11 February 2014 Article: A64

15. Solving strategic problems of medicine of the future on the basis of the foresight methodology

    • Natalia D Pankratova
    • Rostyslav V Bubnov

    Meeting abstract Open access 11 February 2014 Article: A65

16. Introduction to sonosurgery

    • Zbigniew Pilecki
    • Grzegorz Pilecki
    • Rostyslav Bubnov

    Meeting abstract Open access 11 February 2014 Article: A66

17. Apoptosis of stem cells likely determines the manifestation of type 2 diabetic nephropathy: predictive and preventive potentials

    • Mahmood S Mozaffari
    • Jun Yao Liu
    • Babak Baban

    Meeting abstract Open access 11 February 2014 Article: A67

18. The challenge of diabetes treatment in Macedonia

    • Ivica Smokovski

    Meeting abstract Open access 11 February 2014 Article: A68

19. Predictive, preventive and personalized medicine (PPPM) as a strategic avenue and global tool for advancing T1D-related care: Fundamental, Applied and Affiliated Issues

    • Sergey Suchkov
    • Olga Golubnitschaja
    • Harry Schroeder

    Meeting abstract Open access 11 February 2014 Article: A69

20. What did inspire me to write the abstract for the EPMA Congress?

    • Tatjana Josifova

    Meeting abstract Open access 11 February 2014 Article: A70

    

21. Risk detection and risk management for diabetes patients with atrial fibrilation

    • Matthias M Weber
    • Stephan von Bandemer

    Meeting abstract Open access 11 February 2014 Article: A71

22. Quality of life of people suffering from the diabetes type 2 – examination of the influence of various factors to prevent complications

    • Halina Podbielska
    • Katarzyna Madziarska
    • Ewa Demczuk-Włodarczyk

    Meeting abstract Open access 11 February 2014 Article: A72

23. Opportunities of predictive medicine at the treatment of diabetes mellitus complications

    • Maxim Sautin
    • Sergey Suchkov

    Meeting abstract Open access 11 February 2014 Article: A73

24. Foot ulcers in diabetes mellitus patients – protein analysis of wound environment

    • Lucie Vistejnova
    • Milena Kralickova

    Meeting abstract Open access 11 February 2014 Article: A74

25. The German diabetes self-help and its view to personalised medicine- the development of diabetes self-help in Germany since 2011

    • Deutsche Diabetes-Hilfe – Menschen mit Diabetes

    Meeting abstract Open access 11 February 2014 Article: A75

26. Use of ultrasound to enhance PEI-mediated gene delivery in vivo on diabetic model

    • Rostyslav V Bubnov
    • Olena K Toporova
    • Vitaliy A Kordium

    Meeting abstract Open access 11 February 2014 Article: A76

27. Chromium picolinate therapy in pre/diabetes care: recognition of individual risks and outcomes

    • Olga Golubnitschaja
    • Kristina Yeghiazaryan
    • Hans H Schild

    Meeting abstract Open access 11 February 2014 Article: A77

    

28. Gender specific complications in female diabetic patients: an integrative view

    • Olga Golubnitschaja

    Meeting abstract Open access 11 February 2014 Article: A78

29. Validation of biomarkers of diabetic retinopathy for preventing and predictive medicine in diabetic complications

    • Folami Lamoke
    • Sean Shaw
    • Manuela Bartoli

    Meeting abstract Open access 11 February 2014 Article: A79

30. Personalized monitoring of drug therapy effectiveness based on high-throughput analysis of drugs utilization and inflammatory factors closed functional networks in cardiovascular pathogenesis pathologies

    • Svetlana Babak
    • Larisa Litvinova
    • Maksim Patrushev

    Meeting abstract Open access 11 February 2014 Article: A80

31. The guidance of stem cell cardiomyogenic differentiation by bioartificial scaffolds mimicking myocardium structure and biomechanics

    • Caterina Cristallini
    • Elisa Cibrario Rocchietti
    • Claudia Giachino

    Meeting abstract Open access 11 February 2014 Article: A81

    

32. Perspectives on Europe’s health care systems: meeting future challenges through innovative health care strategies

    • Karolina Budych
    • Christoph A Karle
    • Thomas M Helms

    Meeting abstract Open access 11 February 2014 Article: A82

33. Stroke care in West Bohemia – personalised medicine approach

    • Jiri Polivka
    • Jiri Polivka Jr
    • Ondrej Topolcan

    Meeting abstract Open access 11 February 2014 Article: A83

34. Heredity and vascular endothelium: focus on young age

    • Maria E Evsevieva
    • Alexander J Krivoruchko
    • Ekaterina A Andreeva

    Meeting abstract Open access 11 February 2014 Article: A84

35. Effect of calcitonin gene-related peptide antagonist on the mortality by nitrate induced tolerance rats with acute myocardial infarction

    • T Kezeli
    • T Rukhadze
    • M Mirsiashvili

    Meeting abstract Open access 11 February 2014 Article: A85

36. Diagnostic of large vessel aneurysms as applicable to PPPM

    • Dmitry I Cherepakhin
    • Yuri V Belov
    • Vladlen V Bazylev

    Meeting abstract Open access 11 February 2014 Article: A86

37. Coincidence of cardiovascular disease and breast cancer in females: Multi-modal strategies by predictive, preventive and personalised medicine

    • Olga Golubnitschaja
    • Vincenzo Costigliola
    • Hiroyasu Iso

    Meeting abstract Open access 11 February 2014 Article: A87

38. Significant gender-related differences in CVD have been recognised only recently: deficits in female healthcare

    • Olga Golubnitschaja

    Meeting abstract Open access 11 February 2014 Article: A88

39. Study of the digital model of self-regulation system of the heart

    • Anatoliy O Gorbach
    • Rostyslav V Bubnov

    Meeting abstract Open access 11 February 2014 Article: A89

    

40. Gold nanoparticles: challenge of PPPM for heart failure treatment and drug delivery

    • Mykola Ya Spivak
    • Rostyslav V Bubnov
    • Zoia R Ulberg

    Meeting abstract Open access 11 February 2014 Article: A90

41. Screening of vascular pathologies – evidence-based monitoring of prevention efficiency

    • Ulyana B Lushchyk
    • Viktor V Novytskyy
    • Ivanna I Legka

    Meeting abstract Open access 11 February 2014 Article: A91

42. The problem of utilization (detoxification) unsymmetrical dimethylhydrazine. Challenge for synthesis of mildronate and its structure analogues

    • Vadym G Voloshchuk
    • Yuriy L Yagupolskyi
    • Rostyslav V Bubnov

    Meeting abstract Open access 11 February 2014 Article: A92

43. Building a public health network for prevention of suicides in Macedonia in accordance to the German model - “Nuernberg Alliance Against Depression”: “Macedonian Alliance Against Depression”- MAAD

    • Kneginja Richter
    • Mirjana Polazarevska
    • Günter Niklewski

    Meeting abstract Open access 11 February 2014 Article: A93

44. Personalized medicine in common mental disorders

    • Hans Jörgen Grabe

    Meeting abstract Open access 11 February 2014 Article: A94

45. A project of harmonious health renewal in psychoneurological patients on the basis of the personalized algorithms for treatment and rehabilitation

    • Ulyana B Lushchyk
    • Viktor V Novytskyy
    • Ivanna I Legka

    Meeting abstract Open access 11 February 2014 Article: A95

46. From bedside to bench: the needs of clinically-relevant animal models of disease development

    • R Andrew Tasker

    Meeting abstract Open access 11 February 2014 Article: A96

47. Preventive, personalized medicine at the level of key regulatory proteins: updates on activity-dependent neuroprotective protein (ADNP) as a case study

    • Illana Gozes

    Meeting abstract Open access 11 February 2014 Article: A97

48. Serum amyloid-p (SAP), a potential biomarker for Down syndrome fetuses prevention in maternal plasma

    • Athanasios Anagnostopoulos
    • George Th Tsangaris

    Meeting abstract Open access 11 February 2014 Article: A98

49. Innovative strategies for prediction and targeted prevention of glaucoma in healthy vasospastic individuals: context of neurodegenerative pathologies

    • Kristina Yeghiazaryan
    • Josef Flammer
    • Olga Golubnitschaja

    Meeting abstract Open access 11 February 2014 Article: A99

    

50. Monitoring brain functioning with evident based IT-technologies with feedback control

    • Ulyana B Lushchyk
    • Viktor V Novytskyy
    • Ivanna I Legka

    Meeting abstract Open access 11 February 2014 Article: A100